Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Official Gives Policy Update On Lab-Developed Tests

Executive Summary

Most laboratory-developed tests have no regulatory predicates, said FDA's Elizabeth Mansfield, hinting that many may require pre-market submissions that go beyond FDA's 510(k) review standards once the agency initiates plans for active oversight of the category.

You may also be interested in...



FDA's Seyfert-Margolis On Companion Diagnostics Guidance

Industry is anxiously awaiting guidance from FDA on the development of companion diagnostics for drugs that will inform efforts to move towards personalized medicine.

CMS Final Kidney Disease Treatment Model To Encourage More Home Dialysis

The US Medicare agency introduced a new end-stage renal disease treatment model on Friday to incentivize use of home dialysis.

Topics

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel